Discover 224 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Meridian is home to a wide range of active clinical trials focusing on conditions such as diabetes, chronic pain management, and mental health research. Participants in these trials gain access to the latest healthcare innovations while helping shape the future of medical treatments. The city's leading research institutions offer numerous opportunities for both healthy volunteers interested in paid trials and individuals looking for studies targeting specific conditions.
Filter
2
Filter results
Results: 224
Active & Responsive
Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy
for
TBI Traumatic Brain Injury,
Location: Boise ID
Sponsor: Summit Hyperbarics and Wellness
Sex: All
Age: 18 - 70+
Code: NCT07214415
Phase 2, Recruiting
Active & Responsive
HBOT Effects on First Responders' Cognition and Well-Being
for
Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder,
Location: Boise ID
Sponsor: Summit Hyperbarics and Wellness
Sex: All
Age: 18 - 70+
Code: NCT07852728
Phase 2, Recruiting
Active & Responsive
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS: A Biomarker Study
for
Traumatic Brain Injury (TBI) Patients, Post Concussive Symptoms,
Location: Boise ID
Sponsor: Summit Hyperbarics and Wellness
Sex: All
Age: 18 - 70+
Code: NCT07849465
Phase 2, Recruiting
Active & Responsive
Long-Term Outcomes Following HBOT
for
Traumatic Brain Injury, Post-Concussive Symptoms,
Location: Boise ID
Sponsor: Summit Hyperbarics and Wellness
Sex: All
Age: 18+
Code: NCT07732374
Phase 2, Recruiting
A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age
for
Influenza, Human
Location: Meridian ID, Glendale AZ, San Diego CA, Tucson AZ,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 64
Code: NCT07851246
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Meridian ID, Boise ID, Nampa ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Meridian ID, Boise ID, Nampa ID, Caldwell ID,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase 3, Recruiting
Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
for
Non-hematologic Cancer
Location: Boise ID
Sponsor: Sequenom, Inc.
Sex: All
Age: 18+
Code: NCT02586389
Recruiting
Family Communications After Genetic Testing
for
Colon Adenocarcinoma, Colorectal Adenocarcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07143487
Recruiting
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
for
Prostate Cancer Detection
Location: Meridian ID, San Diego CA, Bowling Green KY, Towson MD,
Sponsor: Sequenom, Inc.
Sex: Male
Age: 40 - 70+
Code: NCT07543757
Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03191149
Phase 2, Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Meridian ID, Boise ID, Caldwell ID, Ontario OR,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase 2, Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
for
Castration-Resistant Prostate Carcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,